What Causes Erectile Dysfunction? Symptoms, Risk Factors, and Treatments Explained
Clara Hanson Smith
Erectile dysfunction (ED) is a common condition affecting over 50% of men between 40 and 70 in the UK…
3 min read time
Content
Join our newsletter
Sign up to enjoy regular updates, exclusive promotions, and special offers.
How GLP-1 Medications Can Help Manage PCOS Symptoms
Polycystic Ovary Syndrome (PCOS) affects 1 in 10 women in the UK, making it one of the most common hormonal disorders among women of reproductive age. While the condition presents differently for everyone, common symptoms include irregular periods, acne, weight gain, fertility issues, and increased levels of androgens (male hormones). For many, managing PCOS requires a multi-faceted approach that includes lifestyle changes and medical treatment.
Yet, the recent advances in GLP-1 receptor agonists such as Mounjaro weight loss injections, Wegovy, and Liraglutide, have found a relief for those suffering from PCOS, especially those struggling with weight and insulin resistance.
Understanding GLP-1s
GLP-1 is a hormone that plays a role in regulating appetite, blood sugar levels, and digestion. These medications mimic this natural hormone, helping to control blood glucose and support weight loss and weight management. Originally, these medications were developed to treat diabetes. Today, they are widely prescribed for weight management and are also showing promise in managing PCOS symptoms.
GLP-1s Role in PCOS
Weight Loss: Weight gain and difficulty losing weight is common for those suffering from PCOS, partially due to insulin resistance. GLP-1s regulate appetite, reduce cravings, and trigger a feeling of fullness sooner, making it easier to adopt sustainable weight management. This weight loss (even moderate) can help with managing PCOS symptoms.
Improved Insulin Sensitivity: Insulin resistance is a key feature of PCOS, and a main cause of many PCOS symptoms. By enhancing insulin response, GLP-1s can reduce circulating insulin levels, potentially reduce the risk of developing type 2 diabetes and reduce testosterone levels.
Hormonal Balance: By targeting metabolic factors, GLP-1 medications may help rebalance sex hormones and improve ovulation, which is important for those trying to conceive and help with menstrual regularity.
Lower Inflammation: Chronic low-grade inflammation is common in PCOS. Emerging studies suggest GLP-1s may help reduce inflammation in the body, offering additional health benefits associated with inflammation.
GLP-1 Medications Available
At The Family Chemist, we offer discreet, convenient, and prescription-based access to several GLP-1 medications all clinically approved. Each treatment is available following a secure online consultation.
Period Pain and PCOS
For many women with PCOS, painful, heavy, or irregular periods are a regular reality. We offer two widely used medications to help relieve period-related pain and cramps.
Naproxen – A powerful NSAID (non-steroidal anti-inflammatory) medication that reduces inflammation and offers effective relief from period cramps.
Mefenamic Acid – Another NSAID, this medication is often used to specifically treat period pain and heavy bleeding and has proved particularly helpful for women with PCOS symptoms.
The Bottom Line
PCOS is a complex condition that can affect many aspects of health. It can impact hormones, metabolism, menstrual cycles, and fertility. Treatment for symptoms is a combined approach of lifestyle changes and medication. One group of medications which can offer relief are GLP-1 treatments or more commonly known as weight loss injections which are emerging as an effective tool to aid weight loss/management, improve insulin sensitivity, and support hormonal balance. As research for PCOS grows, treatment options are becoming more personalised and accessible. If you’re suffering from symptoms of PCOS, it’s important to explore all available treatment options. Talk to a healthcare professional and find what works best for you.
How we reviewed this article:
-
Current version
Share:
Blog suggestions
Orforglipron is a once-daily weight loss pill developed by Eli Lilly and marketed in the US as Foundayo. Unlike injectable GLP-1 treatments, it is taken by mouth without food or water restrictions. Here, we explain how orforglipron works, how effective
Orforglipron is a once-daily weight loss pill developed by Eli Lilly and marketed in the US as Foundayo. Unlike injectable GLP-1 treatments, it is taken by mouth without food or water restrictions. Here, we explain how orforglipron works, how effective
The Wegovy pill has been approved in the UK and is expected to become available through regulated providers from 1 July 2026. Learn who may be eligible, how to access it safely and what to expect from this once-daily weight
The Wegovy pill has been approved in the UK and is expected to become available through regulated providers from 1 July 2026. Learn who may be eligible, how to access it safely and what to expect from this once-daily weight
The Wegovy tablet is a once-daily weight loss pill containing semaglutide, offering an alternative to weekly injections. Discover how it works, how much weight people may lose, how it compares with injections and when it could become available in the
The Wegovy tablet is a once-daily weight loss pill containing semaglutide, offering an alternative to weekly injections. Discover how it works, how much weight people may lose, how it compares with injections and when it could become available in the
Related products
Read more about Women's Health
How To Reduce Side Effects Of Finasteride
Clara Hanson Smith
How to the reduce side effects of Finasteride Table of Contents Written by: The Family ChemistMedically reviewed by: Tannaz SohrabiPublished: 30/03/2026 What is Finasteride and how does it work? Finasteride is a commonly prescribed medication for male pattern baldness (androgenetic alopecia) and benign prostatic hyperplasia (BPH). Finasteride works by blocking the
Erectile Dysfunction: Causes and When To Get Treatment
Clara Hanson Smith
Erectile dysfunction (ED) is a common condition affecting over 50% of men between 40 and 70 in the UK…